Although most cancers possess tumor-associated antigens (TAA) that can serve as targets of the immune system, immunity is not effectively induced in most tumor-bearing hosts. Dysregulation of dendritic cell (DC) differentiation, function and trafficking may contribute to tumor immunopathogenesis. Malignant ascites contains viable tumor and immune cells, which we used as a model for the tumor environment. We identified a significant population of PDC, not MDC, in malignant ascites of patients with ovarian carcinoma. Our work demonstrate that tumor PDC induce TAA-specific IL-10+CCR7+CD8+ T cells. These T cells migrate with lymphoid homing molecule CCR7, and suppress MDC mediated TAA-specific protective tumor immunity. Further, MDC cannot recover the suppressive effects. More importantly, we show that tumor-mediated upregulation of PDC B7-H1 contributes to detrimental immunity induced by tumor PDC. We now extend these observations, and further demonstrate in detail the nature of TAA-specific T cell immunity induced by tumor PDC, and the underlying mechanisms. There exists a significant amount of PDC in tumor ascites. Tumor ascites harbors predominantly memory T cells. By examining the interaction between tumor ascites TAA-expressing PDC and tumor memory T cells, Aim 1 is to test our hypothesis that tumor PDC induce TAA-specific suppressive memory CD8+ T cell immunity. Lymph nodes (LNs) are the central priming sites for DC to initiate T cell immunity. LNs harbor predominantly naive T cells. Draining tumor LN-PDC co-localized with naive T cells. By examining the interaction between TAA expressing LN-PDC and LN naive T cells, Aim 2 is to test our hypothesis that draining tumor LNPDC induce TAA-specific suppressive naive CD8+ T cell immunity. B7-H1 is a member of the B7 T cell costimulatory family that induces T cell IL-10 and mediates tolerance/anergy. Tumor PDC highly express B7-H1 whose regulation and functional significance is unknown.
Aim 3 is to test our hypothesis that tumor PDC B7-HI contributes to induce TAA-specific suppressive CD8+ T cell immunity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA092562-04
Application #
7279089
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Howcroft, Thomas K
Project Start
2003-07-01
Project End
2008-04-30
Budget Start
2006-08-29
Budget End
2007-04-30
Support Year
4
Fiscal Year
2005
Total Cost
$259,124
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Surgery
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Nagarsheth, Nisha; Wicha, Max S; Zou, Weiping (2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17:559-572
Zhao, Ende; Maj, Tomasz; Kryczek, Ilona et al. (2016) Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol 17:95-103
Zou, Weiping; Wolchok, Jedd D; Chen, Lieping (2016) PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med 8:328rv4
Thomas, Duncan C; Conti, David V; Baurley, James et al. (2009) Use of pathway information in molecular epidemiology. Hum Genomics 4:21-42
Wei, Shuang; Curiel, Tyler; Coukos, George et al. (2008) Inhibitory B7 family members in human ovarian carcinoma. Adv Exp Med Biol 622:261-71
Kryczek, Ilona; Wei, Shuang; Zhu, Gefeng et al. (2007) Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 67:8900-5
Wei, Shuang; Kryczek, Ilona; Edwards, Robert P et al. (2007) Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. Cancer Res 67:7487-94
Kryczek, Ilona; Wei, Shuang; Zou, Linhua et al. (2006) Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 177:40-4
Kryczek, Ilona; Zou, Linhua; Rodriguez, Paulo et al. (2006) B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203:871-81
Wei, Shuang; Kryczek, Ilona; Zou, Linhua et al. (2005) Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 65:5020-6

Showing the most recent 10 out of 16 publications